Ind Swift Labs (Active Pharmaceutical Ingredients Business) is Pharmaceuticals in India that focus on related pharmaceutical ingredients business. They cover business area such as manufacturer, pharmaceutical ingredient, good health, cardiovascular, macrolide antibiotic, its client.
-
Related Pharmaceutical Ingredients
-
E-5, Industrial Area
Phase-II
Mohali, Punjab 160055
India
Private
manufacturerpharmaceutical ingredientgood healthcardiovascular, macrolide antibioticits client
* We use standard office opening hours in near Ind Swift Labs (Active Pharmaceutical Ingredients Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ind Swift Labs (Active Pharmaceutical Ingredients Business) is Pharmaceuticals business from India that founded in - ( years old in ), Ind Swift Labs (Active Pharmaceutical Ingredients Business) business is focusing on Related Pharmaceutical Ingredients.
Ind Swift Labs (Active Pharmaceutical Ingredients Business) headquarter office and corporate office address is located in E-5, Industrial Area Phase-II Mohali, Punjab 160055 India.
Ind Swift Labs (Active Pharmaceutical Ingredients Business) was founded in India.
In , Ind Swift Labs (Active Pharmaceutical Ingredients Business) is currently focus on related pharmaceutical ingredients sector.
Above is snippet of Google Trends for "related pharmaceutical ingredients" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ind Swift Labs (Active Pharmaceutical Ingredients Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
